ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Institute of Hematology & Blood Diseases Hospital, China · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
treatment
immune thrombocytopenia, treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 866685
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.